Ethos Technologies Inc. - Class A Common Stock (LIFE)

22.83
+2.41 (11.80%)
NASDAQ· Last Trade: Aug 3rd, 6:21 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Ethos Technologies Inc. Class A Common Stock Q2 Earnings Call Highlightsmarketbeat.com
Ethos Technologies Inc. Class A Common Stock (NASDAQ:LIFE) reported second-quarter fiscal 2026 revenue of $189.6 million, up 113% from a year earlier, as growth accelerated across its direct-to-consumer and third-party agency channels. The company also raised its full-year revenue and adjusted EBITD
Via MarketBeat · August 3, 2026
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · August 3, 2026
Ethos Technologies Shares Tumble As Bear Cave Takes Aimbenzinga.com
Shares of Ethos Technologies Inc (NASDAQ: LIFE) are trading sharply lower on Thursday after short-selling newsletter The Bear Cave published a highly critical report on the digital life insurance company.
Via Benzinga · May 21, 2026
Ethos (LIFE) Q1 2026 Earnings Call Transcriptfool.com
Ethos (LIFE) Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 6, 2026
ETHOS TECHNOLOGIES INC CL-A (NASDAQ:LIFE) Revenue Beat and Profitability Surprise Masked by GAAP Loss and Stock Compensationchartmill.com
Via Chartmill · May 6, 2026
Recap: aTyr Pharma Q4 Earningsbenzinga.com
Via Benzinga · March 14, 2024
2 Small-Cap Biotech Stocks Well Positioned for a Breakoutfool.com
Clinical trial results expected in the weeks ahead could push shares of these small-cap drugmakers through the roof.
Via The Motley Fool · August 27, 2025
3 Innovation Stocks With Parabolic Upside Potentialfool.com
These three growth stocks might be deeply undervalued.
Via The Motley Fool · August 8, 2025
1 Small-Cap Biotech Stock Poised for a Breakoutfool.com
This developmental biotech is nearing a key inflection point.
Via The Motley Fool · August 6, 2025
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025investorplace.com
These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real.
Via InvestorPlace · June 5, 2024
LIFE Stock Earnings: aTyr Pharma Beats EPS, Beats Revenue for Q1 2024investorplace.com
LIFE stock results show that aTyr Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 2, 2024
aTyr Pharma's Earnings Outlookbenzinga.com
Via Benzinga · March 13, 2024
Analyst Expectations for aTyr Pharma's Futurebenzinga.com
Via Benzinga · September 21, 2023
The Latest Analyst Ratings for aTyr Pharmabenzinga.com
Via Benzinga · May 23, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · April 9, 2024
3 Penny Stocks That Could Be Multibaggers in the Making: March Editioninvestorplace.com
Penny stocks are incredibly risky. However, if you can handle the heat, these ideas might be worth your while.
Via InvestorPlace · March 26, 2024
LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023investorplace.com
LIFE stock results show that aTyr Pharma missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 14, 2024
The 3 Best Penny Stocks to Buy in February 2024investorplace.com
With proposed FED rate cuts incoming, these are the penny stocks that are likely to see a spark into new rallies.
Via InvestorPlace · February 15, 2024
$12M Bet On This Trucking Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buyingbenzinga.com
The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · August 2, 2023
aTyr Pharma: Q1 Earnings Insightsbenzinga.com
Via Benzinga · May 9, 2023
Earnings Scheduled For March 14, 2024benzinga.com
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via Benzinga · March 14, 2024
aTyr Pharma's Cash Runway Secured till 2026, Despite Lack of Material Catalysts: Oppenheimer Analystbenzinga.com
Oppenheimer has downgraded aTyr Pharma Inc (NASDAQ: LIFE) to Perform from Outperform, citing a few material catalysts in the next few quarters.
Via Benzinga · July 5, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023benzinga.com
Via Benzinga · July 5, 2023
7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023investorplace.com
Bard AI has consistently outperformed, and it has identified seven growth stocks that it believes will deliver triple-digit returns.
Via InvestorPlace · June 28, 2023
3 Stocks and Cryptos With the Highest Potential Returnsinvestorplace.com
If you're only worried about upside, these stocks and cryptos have some of the highest possible returns in the market.
Via InvestorPlace · May 7, 2023